Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2020 / Articles / Mar / Waste Not, Want Not
Manufacture Quality & Compliance Small Molecules Small Molecules

Waste Not, Want Not

Which techniques best remove residual pharmaceuticals from wastewater?

By Maryam Mahdi 03/03/2020 1 min read

Share

This article is part of our special focus on "traditional" pharma: The Small Molecule Manufacturer (read more here). You can find more articles from The Small Manufacturer here.

Researchers from the University of Buffalo and the Stony Brook University School of Marine and Atmospheric Sciences have identified two techniques – ozonation and the use of granular activated carbon — as being most effective in removing pharmaceuticals from wastewater (1). The techniques were shown to be able to remove up to 95 percent of drugs, including antibiotics and antidepressants. The widespread presence of pharmaceuticals in water sources has been a long-held concern for many within the scientific and environmental communities.

They are now turning their attention to addressing the secondary effects of using the wastewater treatment plant (WWTP) techniques they investigated. For example, it’s possible that ozonation may introduce new compounds, including degradation by-products of pharmaceuticals.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. DS Aga et al. “Assessing pharmaceutical removal and reduction in toxicity provided by advanced wastewater treatment systems.” Environmental Science: Water Research & Technology. (2020)

About the Author(s)

Maryam Mahdi

After finishing my degree, I envisioned a career in science communications. However, life took an unexpected turn and I ended up teaching abroad. Though the experience was amazing and I learned a great deal from it, I jumped at the opportunity to work for Texere. I'm excited to see where this new journey takes me!

More Articles by Maryam Mahdi

False

Advertisement

Recommended

False

Related Content

Innovating Pharmaceutical Packaging
Quality & Compliance Supply Chain
Innovating Pharmaceutical Packaging

March 25, 2025

3 min read

Michiel van den Berg sheds light on the challenges and opportunities facing the industry as it adapts to new materials and regulatory requirements, offering expert insights into the future of pharmaceutical packaging.

AI Approach to Transdermal GLP-1s
Advanced Medicine Bioprocessing - Single Use Systems Bioprocessing - Upstream & Downstream Dosage Forms Contract Manufacturing Services Biosimilars Packaging Process Control Supply Chain Quality & Compliance
AI Approach to Transdermal GLP-1s

February 25, 2025

3 min read

How do you design, refine, and optimize novel GLP-1 drugs that could improve patient experiences? With a computer, of course.

Using the Right Excipients to Mitigate Nitrosamine Formation
Formulation Quality & Compliance Small Molecules
Using the Right Excipients to Mitigate Nitrosamine Formation

January 21, 2025

3 min read

In 2018, nitrosamines were discovered in some pharmaceuticals. The industry has since been under pressure to reduce the risks in both in-development and on-market drug products.

Ambition, Innovation, Impact: The Future of Cleanroom Standards
Process Control Quality & Compliance Standards & Regulation
Ambition, Innovation, Impact: The Future of Cleanroom Standards

December 4, 2024

5 min read

The rocket-fueled dreams of a young engineer applied to the cleanroom industry. Sitting down with Kevin Kyle, CEO, Germfree, who shares insights on the dynamic landscape of cleanroom design and deployment.

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.